Igo-ogan, Baby Girl -.

HRN: 23-59-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/29/2023
09/05/2023
IV
45mg
Q12
Thickly MSAF
08/29/2023
AMPICILLIN 1GM (VIAL)
08/29/2023
09/05/2023
IV
150mg
Q12
Thickly MSAF
Waiting Final Action 
09/01/2023
CEFOTAXIME 500MG (VIAL)
09/01/2023
09/07/2023
IV
150mg
Q12hrs
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: